Back to search

Article

The complex development of psoralen-interstrand crosslink resistance in <i>Escherichia coli</i> requires AcrR inactivation, retention of a <i>marbox</i> sequence, and one of three MarA, SoxS, or Rob global regulators

2024-12-07

Abstract excerpt

Crosslinking agents, such as psoralen and UVA radiation, can be effectively used as antimicrobials and for treating several dysplastic conditions in humans, including some cancers. Yet, both cancer cells and bacteria can become resistant to these compounds, making it important to understand how resistance develops. Recently, several mutants were isolated that developed high-levels of resistance to these compounds...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
97bc640c-50e2-515a-8ad9-a0ab03c01356
DOI
10.1101/2024.12.03.626702
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The complex development of psoralen-interstrand crosslink resistance in <i>Escherichia coli</i> requires AcrR inactivation, retention of a <i>marbox</i> sequence, and one of three MarA, SoxS, or Rob global regulatorsDOI 10.1101/2024.12.03.626702
Select a neighboring publication to make it the new centre.